These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9754549)

  • 1. The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed.
    Wolf PR; Tourne S; Miyazaki T; Benoist C; Mathis D; Ploegh HL
    Eur J Immunol; 1998 Sep; 28(9):2605-18. PubMed ID: 9754549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
    Honey K; Forbush K; Jensen PE; Rudensky AY
    J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-2M molecules, like MHC class II molecules, are targeted to parasitophorous vacuoles of Leishmania-infected macrophages and internalized by amastigotes of L. amazonensis and L. mexicana.
    Antoine JC; Lang T; Prina E; Courret N; Hellio R
    J Cell Sci; 1999 Aug; 112 ( Pt 15)():2559-70. PubMed ID: 10393812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative defect in staphylococcal enterotoxin A binding and presentation by HLA-DM-deficient T2.Ak cells corrected by transfection of HLA-DM genes.
    Albert LJ; Denzin LK; Ghumman B; Bangia N; Cresswell P; Watts TH
    Cell Immunol; 1998 Jan; 183(1):42-51. PubMed ID: 9578718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation.
    Fallas JL; Tobin HM; Lou O; Guo D; Sant'Angelo DB; Denzin LK
    J Immunol; 2004 Aug; 173(3):1549-60. PubMed ID: 15265882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
    Singh N; Van Kaer L
    J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
    Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
    Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes.
    Brooks AG; Campbell PL; Reynolds P; Gautam AM; McCluskey J
    J Immunol; 1994 Dec; 153(12):5382-92. PubMed ID: 7989744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes.
    Tourne S; Miyazaki T; Wolf P; Ploegh H; Benoist C; Mathis D
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9255-60. PubMed ID: 9256469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
    Albert LJ; Ghumman B; Watts TH
    J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional role of class II-associated invariant chain peptide (CLIP) in its ability to variably modulate immune responses.
    Chaturvedi P; Hengeveld R; Zechel MA; Lee-Chan E; Singh B
    Int Immunol; 2000 Jun; 12(6):757-65. PubMed ID: 10837403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC class II expression in double mutant mice lacking invariant chain and DM functions.
    Kenty G; Martin WD; Van Kaer L; Bikoff EK
    J Immunol; 1998 Jan; 160(2):606-14. PubMed ID: 9551894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
    J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing.
    Bellemare-Pelletier A; Tremblay J; Beaulieu S; Boulassel MR; Routy JP; Massie B; Lapointe R; Thibodeau J
    J Leukoc Biol; 2005 Jul; 78(1):95-105. PubMed ID: 15817706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
    J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
    Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
    Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S; Humphreys RE
    Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular antigen processing and presentation by immature dendritic cells.
    Santambrogio L; Sato AK; Carven GJ; Belyanskaya SL; Strominger JL; Stern LJ
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15056-61. PubMed ID: 10611337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonclassical MHC class II molecules.
    Alfonso C; Karlsson L
    Annu Rev Immunol; 2000; 18():113-42. PubMed ID: 10837054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.